Cumberland Pharmaceuticals  logo
Cumberland Pharmaceuticals CPIX
$ 1.06 -1.85%

Quarterly report 2024-Q3
added 11-08-2024

report update icon

Cumberland Pharmaceuticals Financial Ratios 2011-2024 | CPIX

Annual Financial Ratios Cumberland Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-13.1 -13.0 -14.3 -21.5 -12.2 -13.8 -107.9 113.4 42.2 -42.0 14.3 21.8

P/S

3.5 6.0 1.3 1.6 2.1 2.7 3.1 2.5 2.8 2.8 1.7 2.4

EPS

-0.2 -0.3 -0.2 -0.2 -0.5 -0.5 -0.1 0.0 0.1 -0.1 0.3 0.3

EV (Enterprise Value)

69.2 M 64.9 M 72.5 M 101 M 114 M 94.3 M 87.7 M 59.8 M 77.1 M 55.8 M 42.2 M 65.6 M

EBITDA per Share

0.21 0.02 -0.13 0.0332 -0.296 -0.103 0.0469 0.186 0.293 -0.158 0.475 0.522

EV/EBITDA

-19.4 -20.6 130.0 -16.7 -45.5 94.0 15.0 12.1 -16.3 3.6 5.4

PEG

-0.16 0.08 -2.51 -0.44 -1.22 0.02 0.46 -1.66 0.19 0.31 1.94 0.17

P/B

0.9 1.2 1.0 1.5 1.5 1.7 1.4 1.1 1.3 1.1 1.0 1.5

P/CF

3.8 7.9 14.4 37.4 -73.1 -54.0 -65.3 26.1 29.9 -13.0 18.2 14.9

ROE %

-6.73 -8.99 -7.12 -6.93 -12.53 -12.48 -1.29 0.95 3.00 -2.65 6.83 6.83

ROA %

-2.63 -4.56 -3.46 -3.38 -6.18 -8.56 -1.01 0.80 2.54 -2.40 5.93 5.92

ROCE %

-6.28 -10.17 -9.01 -4.51 -8.71 -5.40 -1.82 1.40 4.36 -4.75 9.74 11.20

Current Ratio

1.6 2.0 1.9 2.1 2.1 3.9 4.4 5.4 5.2 9.1 10.8 13.2

DSO

400.9 422.4 120.7 75.1 70.3 74.5 81.0 66.2 54.4 51.6 45.0 50.5

DIO

366.1 394.9 448.7 392.5 597.5 333.7 329.0 313.7 404.5 384.0 449.8 393.1

DPO

409.5 477.2 565.1 496.8 548.8 444.7 492.3 211.4 234.2 136.6 201.8 103.0

Operating Cycle

767.0 817.3 569.4 467.6 667.8 408.1 410.1 379.9 459.0 435.7 494.7 443.6

Cash Conversion Cycle

357.5 340.2 4.3 -29.2 119.0 -36.6 -82.2 168.5 224.7 299.0 292.9 340.6

All numbers in USD currency

Quarterly Financial Ratios Cumberland Pharmaceuticals

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.11 -0.08 - -0.07 0.06 0.01 - -0.03 -0.09 -0.09 -0.26 -0.07 0.08 0.01 -0.06 -0.03 -0.06 -0.07 -0.06 -0.13 -0.13 - -0.14 -0.11 -0.05 -0.15 -0.05 -0.05 -0.32 -0.08 -0.05 0.01 - -0.02 0.01 0.01 0.02 - 0.04 0.04 0.04 0.02 -0.08 -0.04 -0.03 0.05 0.09 0.1 0.09 0.02 0.05 0.09 0.11 0.04

EBITDA per Share

-0.04 0.01 - -0.05 0.08 -0.02 - 0.08 -0.02 0.02 -0.3 0.13 0.07 0.06 -0.12 0.15 0.05 -0.05 -0.22 -0.14 0.01 -0.02 -0.21 -0.03 -0.03 -0.17 -0.06 0.07 -0.02 - -0.06 0.12 0.07 - 0.01 0.12 0.11 0.03 0.06 0.14 0.11 0.04 -0.14 -0.03 -0.03 0.09 0.17 0.19 0.12 0.04 0.09 0.19 0.2 0.08

ROE %

-16.24 -7.64 -0.10 -1.15 0.74 -5.03 -7.90 -16.88 -18.09 -12.13 -8.38 -1.28 -0.04 -4.55 -7.11 -7.11 -9.86 -11.72 -9.61 -11.71 -10.87 -8.34 -12.47 -9.74 -7.96 -14.72 -12.44 -12.22 -10.91 -2.93 -1.29 -0.07 -0.05 0.55 0.95 1.58 2.34 2.71 3.00 0.28 -1.67 -3.37 -2.65 1.35 4.56 7.40 6.82 5.81 5.86 6.45 6.82 2.23 2.63 0.87

ROA %

-5.79 -2.80 -0.03 -0.48 0.27 -2.15 -3.34 -7.90 -8.65 -5.83 -4.23 -0.59 0.12 -2.21 -3.46 -3.46 -4.85 -5.76 -4.73 -5.79 -5.36 -4.13 -6.18 -5.07 -4.41 -9.30 -8.56 -8.50 -7.59 -2.11 -1.01 -0.04 -0.02 0.47 0.80 1.33 1.98 2.29 2.54 0.13 -1.59 -3.08 -2.40 1.14 3.97 6.47 5.93 5.05 5.09 5.60 5.92 1.93 2.28 0.75

ROCE %

-21.20 -14.30 -9.42 -10.16 -5.67 -10.44 -8.62 -18.79 -21.40 -19.69 -17.22 -10.76 -9.98 -10.34 -13.58 -16.50 -20.11 -23.00 -21.46 -20.72 -19.27 -16.46 -20.01 -15.52 -12.09 -11.28 -6.37 -6.26 -4.78 -2.30 -1.96 -0.44 -0.26 0.76 1.45 2.41 3.28 3.91 4.41 0.12 -3.01 -5.95 -4.78 2.12 7.51 11.20 10.29 8.56 8.82 10.93 11.88 3.74 4.38 1.70

Current Ratio

1.5 1.5 1.6 1.7 1.7 1.7 1.6 1.7 1.7 1.7 2.0 2.1 2.2 2.0 1.9 1.9 1.9 1.9 2.0 2.0 2.0 1.9 2.0 2.0 2.0 2.0 3.2 3.2 3.2 3.2 4.6 4.6 4.6 4.6 6.1 6.1 6.1 6.1 6.5 6.5 6.5 6.5 10.5 10.5 10.5 10.5 7.6 7.6 7.6 7.6 7.5 7.5 7.5 7.5

DSO

115.2 99.0 - 112.4 112.1 137.0 - 114.0 123.7 87.8 91.7 107.4 109.3 107.9 110.1 122.1 117.7 110.8 79.2 106.2 86.3 85.9 62.2 122.3 70.4 86.3 65.8 68.4 88.4 74.5 73.7 76.1 90.2 79.1 69.0 70.3 62.2 60.8 53.8 51.6 51.5 56.6 50.7 63.3 58.4 46.9 40.1 43.8 44.4 58.3 49.6 49.5 44.9 -

DIO

303.9 237.6 - 506.5 633.3 731.4 - 411.6 433.4 377.6 - 699.7 527.2 389.7 - 453.0 371.9 544.7 - 540.8 182.5 578.8 - 754.7 723.5 561.9 - 283.8 - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

847.2 707.9 - 561.5 664.1 804.3 - 453.3 494.9 435.0 - 625.1 509.3 450.4 - 570.5 468.4 653.0 - 525.9 174.9 481.4 - 693.1 664.5 599.4 - 378.2 - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

419.0 336.7 - 618.8 745.4 868.4 - 525.6 557.0 465.5 91.7 807.1 636.6 497.7 110.1 575.1 489.6 655.5 79.2 647.0 268.9 664.7 62.2 876.9 794.0 648.1 65.8 352.2 88.4 74.5 73.7 76.1 90.2 79.1 69.0 70.3 62.2 60.8 53.8 51.6 51.5 56.6 50.7 63.3 58.4 46.9 40.1 43.8 44.4 58.3 49.6 49.5 44.9 -

Cash Conversion Cycle

-428.1 -371.2 - 57.3 81.3 64.1 - 72.2 62.1 30.5 91.7 181.9 127.3 47.3 110.1 4.7 21.2 2.5 79.2 121.0 94.0 183.3 62.2 183.8 129.4 48.7 65.8 -26.0 88.4 74.5 73.7 76.1 90.2 79.1 69.0 70.3 62.2 60.8 53.8 51.6 51.5 56.6 50.7 63.3 58.4 46.9 40.1 43.8 44.4 58.3 49.6 49.5 44.9 -

All numbers in USD currency